Radioprotective and antioxidant effect of resveratrol in hippocampus by activating Sirt1

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 5928-5939

  Li, Jianguo ^a,b   Feng, Li ^a   Xing, Yonghua ^a   Wang, Yan ^a   Du, Liqing ^a   Xu, Chang ^a   Cao, Jia ^a   Wang, Qin ^a   Fan, Saijun ^a   Liu, Qiang ^a   Fan, Feiyue ^a  

^a INSTITUTE OF RADIATION MEDICINE   (China)

^b INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Hippocampus; Radiation; Reactive oxygen species; Resveratrol; Sirtuin 1

Indexed keywords

REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN 1; ANTIOXIDANT; MESSENGER RNA; RADIOPROTECTIVE AGENT; RIBONUCLEOTIDE REDUCTASE; SIRT1 PROTEIN, RAT; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; IMMUNOHISTOLOGY; IRRADIATION; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION PROTECTION; RAT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; RADIATION RESPONSE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; ENZYME ACTIVATION; HIPPOCAMPUS; MALE; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RIBONUCLEOTIDE REDUCTASES; RNA, MESSENGER; SIRTUIN 1; STILBENES;

EID: 84898656748     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15045928     Document Type: Article

References (42)

1. Arora, R.; Gupta, D.; Chawla, R.; Sagar, R.; Sharma, A.; Kumar, R.; Prasad, J.; Singh, S.; Samanta, N.; Sharma, R.K. Radioprotection by plant products: Present status and future prospects. Phytother. Res. 2005, 19, 1-22.
2. Jagetia, G.C. Radioprotective potential of plants and herbs against the effects of ionizing radiation. J. Clin. Biochem. Nutr. 2007, 40, 74-81.
3. Maisin, J.R. Bacq and Alexander award lecture chemical radioprotection: Past, present and future prospects. Int. J. Radiat. Biol. 1998, 73, 443-450.
4. Nair, C.K.K.; Parida, D.K.; Nomura, T. Radioprotectorsin radiotherapy. J. Radiat. Res. 2001, 42, 21-37.
5. Zuo, L.; Motherwell, M.S. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease. Gene 2013, 532, 18-23.
6. Sochocka, M.; Koutsouraki, E.S.; Gasiorowski, K.; Leszek, J. Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer's disease: A new approach to therapy. CNS Neurol. Disord. Drug Targets 2013, 12, 870-881.
7. Hou, J.; Han, Z.P.; Jing, Y.Y.; Yang, X.; Zhang, S.S.; Sun, K.; Hao, C.; Meng, Y.; Yu, F.H.; Liu, X.Q., et al. Autophagy prevents irradiation injury and maintains stemness through decreasing ROS generation in mesenchymal stem cells. Cell Death Dis. 2013, 4, e844.
8. Halliwell, B. Reactive oxygen species and the central nervous system. J. Neurochem. 1992, 59, 1609-1623.
9. Wong, C.S.; van der Kogel, A.J. Mechanisms of radiation injury to the central nervous system: Implications for neuroprotection. Mol. Interv. 2004, 4, 273-284.
10. Siegal, T.; Pfeffer, M.R.; Meltzer, A.; Shezen, E.L.; Nimrod, A.; Ezov, N.; Ovadia, H. Cellular and secretory mechanisms related to delayed radiation-induced microvessel dysfunction in the spinal cord of rats. Int. J. Radiat. Oncol. Biol. Phys. 1996, 36, 649-659.
11. Chong, Z.Z.; Shang, Y.C.; Wang, S.; Maiese, K. SIRT1: New avenues of discovery for disorders of oxidative stress. Expert Opin. Ther. Targets 2012, 16, 167-178.
12. Nakata, R.; Takahashi, S.; Inoue, H. Recent advances in the study on resveratrol. Biol. Pharm. Bull. 2012, 35, 273-279.
13. Gruber, J.; Tang, S.Y.; Halliwell, B. Evidence for a trade-off between survival and fitness caused by resveratrol treatment of caenorhabditis elegans. Ann. N. Y. Acad. Sci. 2007, 1100, 530-542.
14. Pasinetti, G.M.; Wang, J.; Marambaud, P.; Ferruzzi, M.; Gregor, P.; Knable, L.A.; Ho, L. Neuroprotective and metabolic effects of resveratrol: Therapeutic implications for Huntington's disease and other neurodegenerative disorders. Exp. Neurol. 2011, 232, 1-6.
15. Brasnyó, P.L.; Molnár, G.A.; Mohás, M.; Markó, L.; Laczy, B.; Cseh, J.; Mikolás, E.; Szijártó, I.A.; Mérei, A.; Halmai, R., et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 2011, 106, 383-389.
16. Bradamante, S.; Barenghi, L.; Villa, A. Cardiovascular protective effects of resveratrol. Cardiovasc. Drug Rev. 2004, 22, 169-188.
17. Zhang, H.; Zhai, Z.; Wang, Y.; Zhang, J.; Wu, H.; Wang, Y.; Li, C.; Li, D.; Lu, L.; Wang, X., et al. Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic. Biol. Med. 2013, 54, 40-50.
18. Hasegawa, K.; Wakino, S.; Yoshioka, K.; Tatematsu, S.; Hara, Y.; Minakuchi, H.; Washida, N.; Tokuyama, H.; Hayashi, K.; Itoh, H. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem. Biophys. Res. Commun. 2008, 372, 51-56.
19. Chong, Z.Z.; Lin, S.H.; Li, F.; Maiese, K. The Sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through Akt, Bad, PARP, and mitochondrial associated "antiapoptotic" pathways. Curr. Neurovasc. Res. 2005, 2, 271-285.
20. Chong, Z.Z.; Maiese, K. Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and Sirtuin mediated pathways. Curr. Neurovasc. Res. 2008, 5, 159-170.
21. Tanno, M.; Kuno, A.; Yano, T.; Miura, T.; Hisahara, S.; Ishikawa, S.; Shimamoto, K.; Horio, Y. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J. Biol. Chem. 2010, 285, 8375-8382.
22. Kume, S.; Haneda, M.; Kanasaki, K.; Sugimoto, T.; Araki, S.; Isono, M.; Isshiki, K.; Uzu, T.; Kashiwagi, A.; Koya, D. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic. Biol. Med. 2006, 40, 2175-2182.
23. Hou, J.; Wang, S.; Shang, Y.C.; Chong, Z.Z.; Maiese, K. Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress. Curr. Neurovasc. Res. 2011, 8, 220-235.
24. Orallo, F. Trans-resveratrol: A magical elixir of eternal youth? Curr. Med. Chem. 2008, 15, 1887-1898.
25. Balestrazzi, A.; Bonadei, M.; Calvio, C.; Mattivi, F.; Carbonera, D. Leaf-associated bacteria from transgenic white poplar producing resveratrol-like compounds: Isolation, molecular characterization, and evaluation of oxidative stress tolerance. Can. J. Microbiol. 2009, 55, 829-840.
26. Vidavalur, R.; Otani, H.; Singal, P.K.; Maulik, N. Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp. Clin. Cardiol. 2006, 11, 217-225.
27. Fremont, L. Biological effects of resveratrol. Life Sci. 2000, 66, 663-673.
28. Baur, J.A.; Sinclair, D.A. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 2006, 5, 493-506.
29. Robich, M.P.; Osipov, R.M.; Nezafat, R.; Feng, J.; Clements, R.T.; Bianchi, C.; Boodhwani, M.; Coady, M.A.; Laham, R.J.; Sellke, F.W. Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. Circulation 2010, 122, 142-149.
30. Sun, A.Y.; Wang, Q.; Simonyi, A.; Sun, G.Y. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol. Neurobiol. 2010, 41, 375-383.
31. Chung, J.H.; Manganiello, V.; Dyck, J.R.B. Resveratrol as a calorie restriction mimetic: Therapeutic implications. Trends Cell Biol. 2012, 22, 546-554.
32. Ogawa, K.; Tsuruma, K.; Tanaka, J.; Kakino, M.; Kobayashi, S.; Shimazawa, M.; Hara, H. The protective effects of bilberry and lingonberry extracts against UV light-induced retinal photoreceptor cell damage in vitro. J. Agric. Food Chem. 2013, 61, 10345-10353.
33. Simsek, Y.; Gurocak, S.; Turkoz, Y.; Akpolat, N.; Celik, O.; Ozer, A.; Yilmaz, E.; Turhan, U.; Ozyalin, F. Ameliorative effects of resveratrol on acute ovarian toxicityinduced by total body irradiation in young adult rats. J. Pediatr. Adolesc. Gynecol. 2012, 25, 262-266.
34. Mudò, G.; Mäkelä, J.; di Liberto, V.; Tselykh, T.V.; Olivieri, M.; Piepponen, P.; Eriksson, O.; Mälkiä, A.; Bonomo, A.; Kairisalo, M., et al. Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Cell. Mol. Life Sci. 2012, 69, 1153-1165.
35. Chung, S.; Yao, H.; Caito, S.; Hwang, J.W.; Arunachalam, G.; Rahman, I. Regulation of SIRT1 in cellular functions: Role of polyphenols. Arch. Biochem. Biophys. 2010, 501, 79-90.
36. Baur, J.A.; Pearson, K.J.; Price, N.L.; Jamieson, H.A.; Lerin, C.; Kalra, A.; Prabhu, V.V.; Allard, J.S.; Lopez-Lluch, G.; Lewis, K., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444, 337-342.
37. Kang, Y.; Jung, W.Y.; Lee, H.; Lee, E.; Kim, A.; Kim, B.H. Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma. Korean J. Pathol. 2012, 46, 523-531.
38. Matsushita, T.; Sasaki, H.; Takayama, K.; Ishida, K.; Matsumoto, T.; Kubo, S.; Matsuzaki, T.; Nishida, K.; Kurosaka, M.; Kuroda, R. The overexpression of SIRT1 inhibited osteoarthritic gene expression changes induced by interleukin-1β in human chondrocytes. J. Orthop. Res. 2013, 31, 531-537.
39. Chen, F.; Xu, C.; Du, L.; Wang, Y.; Cao, J.; Fu, Y.; Guo, Y.; Liu, Q.; Fan, F. Tat-SmacN7 induces radiosensitization in cancer cells through the activation of caspases and induction of apoptosis. Int. J. Oncol. 2013, 42, 985-992.
40. Fu, Y.; Wang, Y.; Du, L.; Xu, C.; Cao, J.; Fan, T.; Liu, J.; Su, X.; Fan, S.; Liu, Q., et al. Resveratrol inhibits ionising irradiation-induced inflammation in MSCs by activating SIRT1 and limiting NLRP-3 inflammasome activation. Int. J. Mol. Sci. 2013, 14, 14105-14118.
41. LeBel, C.P.; Ali, S.F.; McKee, M.; Bondy, S.C. Organometal-induced increases in oxygen reactive species: The potential of 2',7'-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol. Appl. Pharmacol. 1990, 104, 17-24.
42. McGahon, B.M.; Murray, C.A.; Horrobin, D.F.; Lynch, M.A. Age-related changes in oxidative mechanisms and LTP are reversed by dietary manipulation. Neurobiol. Aging 1999, 20, 643-653.